| Date | Title | | | 05/08/12 | Bacterin International Signs Its Third National GPO Contract with Novation|
BELGRADE, Mont., May 8, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces its third national GPO contract, a three-year agreement with Novation, a leading health care supply chain expert and contracting company. The agreement provides Bacterin's full biologic portfolio, including OsteoSponge®, OsteoSelect® DBM Putty, OsteoWrap®, OsteoLoc... |
|  | | 05/03/12 | Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss| Conference Call at 4:30pm ET to Discuss First Quarter 2012 Results
BELGRADE, Mont., May 3, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, today announced its financial results for the first quarter ended March 31, 2012:
2012 Highlights:
Revenue increased 29% to $7.8 million, compared to the $6.0 million for the first quarter of 2011.
Operat... |
| | | 04/24/12 | Bacterin International Holdings, Inc. Schedules First Quarter 2012 Financial Earnings Conference Call| BELGRADE, Mont., April 24, 2012 /PRNewswire via COMTEX/ --Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, will release its financial results for the three months ended March 31, 2012 after the close of regular market trading on Thursday, May 3, 2012. A conference call will follow at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
Conference Call Details:
Date: Thu... |
| | | 04/24/12 | Bacterin Secures Accounts Receivable Credit Facility| BELGRADE, Mont., April 24, 2012 /PRNewswire via COMTEX/ --Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has secured an accounts receivable credit facility with Midcap Financial LLC and Silicon Valley Bank. The revolving loan credit facility allows Bacterin to borrow up to $5 million through January 1, 2015. The facility allows borrowings based upon a predetermined for... |
| |
|
